Monkeypox continues spreading Over the past few weeks, 288 people in the Netherlands have tested positive for monkeypox. The number of new daily infections seems to be slowly increasing. Science Photo Library / ANP
6 people in the Netherlands with monkeypox There are now 6 cases of monkeypox in humans in the Netherlands. Science Photo Library / ANP
First patient with monkeypox in the Netherlands This afternoon, a patient with monkeypox was confirmed in the Netherlands for the first time. RIVM researchers confirmed that the person has monkeypox with a PCR test. Science Photo Library / ANP
Impact of coronavirus outbreak on participation in National Immunisation Programme limited Participation in the vaccinations against mumps, measles and rubella (MMR) and diphtheria, pertussis (whooping cough), tetanus and polio) (DTaP-IPV) has decreased slightly among infants (-1%).
RIVM expands HPV vaccination programme: girls and boys protected from six types of cancer with one vaccine Now not only girls, but also boys will have the opportunity to protect themselves from cancer caused by HPV.
New: NEVO online 2021 RIVM published a new online edition of the Dutch food composition database (NEVO).
The National Immunisation Programme: the number of disease notifications decreased substantially in 2020 In 2020, fewer people fell ill from a disease against which vaccination is included in the National Immunisation Programme than in 2019. This is most likely due to coronavirus measures, such as social distancing, handwashing, and travel restrictions.
Vaccination coverage increases for second consecutive year, by 10% for HPV The percentage of children receiving vaccinations from the National Immunisation Programme rose again last year. Another striking note is the 10% increase in HPV vaccination, rising to 63%.
New WHO protocol for integrated One Health surveillance of antibiotic resistance: the Tricycle protocol The World Health Organization (WHO) has developed a protocol for global One Health surveillance of antimicrobial resistance based on one indicator, Extended Spectrum Beta-Lactamase producing E. WHO
Report on the developments of the National Immunisation Programme: national immunisation coverage increased slightly for the first time in five years National immunisation coverage has increased for the first time in five years, for almost all vaccinations. For children born in 2017, vaccination coverage against mumps, measles and rubella (MMR) increased by 0.7% to 93.6%.